Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China
Condition: Multidrug Resistant Tuberculosis Intervention: Drug: Delamanid Sponsor: Beijing Chest Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials